On-Demand Virtual Conference
Due to social distancing and large group gathering restrictions, ACI’s 8th Annual Legal, Regulatory & Compliance Forum on Dietary Supplements changed its format from an in-person event to a live and interactive virtual conference. If you missed the conference, you can still purchase the recording and watch on your schedule. Watch from wherever you may be, access information delivered by our expert speaker faculty as you would at an onsite event.
Examining the industry’s current political, legislative, and regulatory environment
American Conference Institute (ACI) together with the Council for Responsible Nutrition (CRN) invite you to join us at the Industry’s Premier Legal and Regulatory Dietary Supplements Conference.
ACI and CRN have collaborated to produce an agenda ripe with topics reflecting today’s most pressing industry concerns. It includes more interactive sessions to help explore resolutions to complex new challenges and ongoing obstacles.
2020 Highlights:
- Focus Session on Addressing Inconsistent Interpretations of the Dietary Supplement Definition
- Case Study on the Best Way of Establishing Ingredient Safety: NDI notification vs. GRAS determination
- Spotlight on the Current Status of a Legal Path for CBD in Dietary Supplements
- Think Tank on Increased State Consumer Protection Activity
- Risk Assessment of Innovative Claims and the Use of Influencers in Product Promotion
- Forecast on New FDA Guidance on Certificates of Free Sales
- Trend Analysis for Postbiotics, Prebiotics and Probiotics
- Best Practices Implementation for Meeting Different Retailer-Imposed Quality Requirements
- Supply Chain Integrity, Transparency, and Corporate Social Responsibility Assessment
- And More!
Missed the 2020 conference?
Watch the recording from the comfort of your workplace or home.
Purchase RecordingOur Distinguished 2020 Co-Chairs

Scott Bass
Partner & Head, Global Life Sciences
Sidley Austin LLP
FIRESIDE CHATS WITH THE FDA AND FTC

Steven Tave
Director, Office of Dietary Supplement Programs
U.S. Food and Drug Administration

Serena Viswanathan
Acting Deputy Director
Bureau of Consumer Protection
U.S. Federal Trade Commission
Perspectives from Leading Industry Stakeholders
- Abbott
- Atrium Innovations
- Charlotte’s Web
- Chromadex
- CV Sciences, Inc.
- doTERRA
- Herbalife Nutrition
- Nature’s Bounty
- Neptune Wellness Solutions
- Nutraceutical Corporation
- Papa & Barkley LLC
- Pharmavite
- Procter & Gamble
- RB Health US, LLC
Insights from Key Government Agencies
and Consumer Protection Groups
U.S. Food and Drug Administration
National Advertising Division (NAD) – BBB National Programs, Inc.
U.S. Federal Trade Commission
Post-Conference Workshops are included with this recording:
As an industry-leading event, this conference boasts a longstanding track record of gathering the “who’s who” of legal and regulatory decision makers for the dietary supplement industry.
Purchase the On-Demand recording now!
Join us in 2021
Leading counsel and top regulatory and compliance executives will convene again in 2021 for the 9th Annual LEGAL, REGULATORY & COMPLIANCE FORUM ON DIETARY SUPPLEMENTS for in-depth discussions on new industry developments and to assess the myriad legal, regulatory, and compliance obligations that impact business decisions and long-term strategies.
Keep in Touch. Sign up to our mailing list to receive the most up-to-date conference details.
Join our list
WHAT PAST ATTENDEES HAVE TO SAY
![]()
High quality speakers, relevant current content.
![]()
Topics are timely and important, speakers are well-informed and case studies helpful.
![]()
Comprehensive and In-depth review of leading regulatory issues for the dietary supplement industry.
![]()
Awesome opportunity to learn first hand knowledge from those with expertise in the field of Dietary Supplements.
![]()
As a member of a dietary supplement regulatory affairs department reviewing product content daily for FTC / FDA compliance, it was a valuable experience to be in a room with top minds from around the country who could answer my questions.